A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active Crohn’s disease

Gastroenterology

Volumn 121, Issue 2, 2001, Pages 268-274

  Gordon, Fiona H ^a   Lai, Clement W Y ^b   Hamilton, Mark I ^a   Allison, Miles C ^b   Srivastava, Emmanuel D ^b   Fouweather, Marilyn G ^b   Donoghue, Stephen ^c   Greenlees, Carol ^c   Subhani, Javaid ^a   Amlot, Peter L ^a   Pounder, Roy E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c Elan Pharmaceuticals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; AZATHIOPRINE; BUDESONIDE; INTEGRIN; MESALAZINE; MONOCLONAL ANTIBODY; NATALIZUMAB; PLACEBO; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFUSION; LEUKOCYTE MIGRATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; T LYMPHOCYTE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 0034903450     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.26260     Document Type: Article

References (22)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Lymphocyte homing and homeostasis
3. Characterization of the cell surface heterodimer VLA-4 and related peptides
4. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue
5. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody
6. Acquired increase in leukocyte binding by intestinal microvascular endothelium in inflammatory bowel disease
7. Attenuation of colitis in the cotton-top tamarin by anti-α4 integrin monoclonal antibody
8. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to gut-homing integrin α4β7
9. An ascending dose trial of a humanized α467 antibody in ulcerative colitis (UC)
10. Humanization of a mouse antibody against human alpha-4 integrin: A potential therapeutic for the treatment of multiple sclerosis
11. Prevention of experimental autoimmune encephalomy-elitis by antibodies against α461 integrin
12. The effect of anti-α4 integrin antibody on brain lesion activity in multiple sclerosis
13. A phase I double-blind, placebo-controlled, ascending single intravenous dose, safety, tolerability, pharmacokinetic, immunogenity and potency study in healty male volunteers
14. Development of a Crohn’s disease activity index
15. Differential diagnosis, ulcerative colitis, Crohn’s disease and other disorders including diverticular disease
16. A new measure of health status for clinical trials in inflammatory bowel disease
17. Activation antigen expression on human T cells. I. Analysis by two-color flow cytometry of umbilical cord blood, adult blood and lymphoid tissue
18. Altered expression of (α4b7, a gut-homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation
19. Randomised controlled trial of CDP571 antibody to tumor necrosis factor-α in Crohn’s disease
20. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease
21. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis
22. Distribution of α4b7 and αEb7 integrins on thymocytes, intestinal epithelial lymphocytes and peripheral lymphocytes